CVS Group (LON:CVSG)‘s stock had its “buy” rating reiterated by investment analysts at Peel Hunt in a research note issued on Monday, September 23rd, Digital Look reports. They presently have a GBX 1,050 ($13.72) price target on the stock, up from their previous price target of GBX 950 ($12.41). Peel Hunt’s target price points to a potential upside of 6.71% from the stock’s current price.
Shares of CVSG stock traded down GBX 16 ($0.21) during midday trading on Monday, hitting GBX 984 ($12.86). The company had a trading volume of 458,354 shares, compared to its average volume of 234,115. The company’s 50 day simple moving average is GBX 913.03 and its 200 day simple moving average is GBX 752.58. CVS Group has a 52-week low of GBX 362.40 ($4.74) and a 52-week high of GBX 1,014 ($13.25). The stock has a market cap of $699.45 million and a price-to-earnings ratio of 84.83. The company has a debt-to-equity ratio of 70.20, a current ratio of 1.03 and a quick ratio of 0.70.
CVS Group Company Profile
CVS Group plc engages in veterinary, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practice, Laboratory, Crematoria, and Animed Direct. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation services for veterinary practices and directly for pet owners; and clinical waste collection services, as well as specialist veterinary recruitment services.
Featured Story: What is the QQQ ETF?
Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with MarketBeat.com's FREE daily email newsletter.